| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prenatal Exposure Delayed Effects | 83 | 2024 | 2531 | 4.660 |
Why?
|
| Adiposity | 57 | 2024 | 1890 | 3.900 |
Why?
|
| Fetal Blood | 47 | 2024 | 1369 | 3.030 |
Why?
|
| Fluorocarbons | 26 | 2024 | 497 | 2.920 |
Why?
|
| Body Mass Index | 126 | 2025 | 13039 | 2.310 |
Why?
|
| Pregnancy | 228 | 2024 | 30260 | 2.220 |
Why?
|
| DNA Methylation | 40 | 2024 | 4424 | 2.160 |
Why?
|
| Environmental Pollutants | 27 | 2024 | 1290 | 2.140 |
Why?
|
| Obesity | 74 | 2025 | 13076 | 1.710 |
Why?
|
| Pregnancy Trimester, Second | 29 | 2024 | 737 | 1.510 |
Why?
|
| Diabetes, Gestational | 26 | 2024 | 1263 | 1.510 |
Why?
|
| Alkanesulfonic Acids | 16 | 2024 | 199 | 1.500 |
Why?
|
| Weight Gain | 33 | 2024 | 2355 | 1.500 |
Why?
|
| Mothers | 35 | 2023 | 2210 | 1.410 |
Why?
|
| Maternal Exposure | 20 | 2024 | 1095 | 1.380 |
Why?
|
| Breast Feeding | 29 | 2023 | 1364 | 1.350 |
Why?
|
| Overweight | 28 | 2022 | 2444 | 1.320 |
Why?
|
| Child, Preschool | 173 | 2024 | 42500 | 1.290 |
Why?
|
| Child | 226 | 2025 | 80564 | 1.240 |
Why?
|
| Child Development | 29 | 2024 | 2327 | 1.240 |
Why?
|
| Fetal Development | 14 | 2022 | 777 | 1.210 |
Why?
|
| Pregnancy Complications | 24 | 2024 | 2975 | 1.090 |
Why?
|
| Body Weight | 28 | 2022 | 4622 | 1.090 |
Why?
|
| Diet | 38 | 2024 | 8086 | 1.080 |
Why?
|
| Asthma | 29 | 2024 | 6270 | 1.070 |
Why?
|
| Child Behavior | 10 | 2022 | 865 | 1.050 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 12 | 2022 | 395 | 1.050 |
Why?
|
| Cognition | 28 | 2024 | 7049 | 1.040 |
Why?
|
| Female | 403 | 2025 | 396112 | 1.040 |
Why?
|
| Hypertension, Pregnancy-Induced | 13 | 2024 | 532 | 1.040 |
Why?
|
| Massachusetts | 82 | 2025 | 8875 | 1.010 |
Why?
|
| Prenatal Nutritional Physiological Phenomena | 10 | 2021 | 160 | 1.010 |
Why?
|
| Feeding Behavior | 22 | 2020 | 3212 | 0.990 |
Why?
|
| Birth Weight | 34 | 2024 | 2121 | 0.990 |
Why?
|
| Cesarean Section | 6 | 2021 | 1431 | 0.970 |
Why?
|
| Cohort Studies | 117 | 2025 | 41649 | 0.950 |
Why?
|
| Pregnancy Trimester, First | 19 | 2024 | 919 | 0.950 |
Why?
|
| Body Height | 13 | 2021 | 1562 | 0.940 |
Why?
|
| Infant, Newborn | 103 | 2023 | 26346 | 0.940 |
Why?
|
| Postpartum Period | 21 | 2023 | 1205 | 0.930 |
Why?
|
| Blood Pressure | 31 | 2024 | 8532 | 0.910 |
Why?
|
| Prospective Studies | 128 | 2024 | 54802 | 0.900 |
Why?
|
| Infant | 117 | 2024 | 36386 | 0.860 |
Why?
|
| Mercury | 6 | 2023 | 291 | 0.840 |
Why?
|
| Humans | 442 | 2025 | 765968 | 0.780 |
Why?
|
| Leptin | 13 | 2024 | 1596 | 0.760 |
Why?
|
| Anthropometry | 13 | 2021 | 1338 | 0.720 |
Why?
|
| Epigenesis, Genetic | 24 | 2024 | 3819 | 0.710 |
Why?
|
| Environmental Exposure | 20 | 2025 | 4544 | 0.710 |
Why?
|
| Metals | 6 | 2024 | 710 | 0.710 |
Why?
|
| Acetaminophen | 3 | 2020 | 547 | 0.710 |
Why?
|
| Premature Birth | 11 | 2023 | 1829 | 0.700 |
Why?
|
| Male | 267 | 2025 | 363698 | 0.700 |
Why?
|
| Caprylates | 9 | 2024 | 114 | 0.700 |
Why?
|
| Ibuprofen | 2 | 2019 | 228 | 0.690 |
Why?
|
| Adolescent | 123 | 2025 | 88835 | 0.690 |
Why?
|
| Television | 12 | 2018 | 409 | 0.680 |
Why?
|
| Glucose Intolerance | 10 | 2020 | 580 | 0.680 |
Why?
|
| Respiratory Sounds | 11 | 2021 | 705 | 0.680 |
Why?
|
| Sleep Deprivation | 7 | 2017 | 845 | 0.670 |
Why?
|
| Air Pollution | 12 | 2023 | 2380 | 0.660 |
Why?
|
| Infertility | 5 | 2024 | 654 | 0.650 |
Why?
|
| Executive Function | 11 | 2022 | 1391 | 0.650 |
Why?
|
| Waist Circumference | 15 | 2024 | 932 | 0.640 |
Why?
|
| Adiponectin | 12 | 2025 | 1119 | 0.640 |
Why?
|
| Infant Nutritional Physiological Phenomena | 5 | 2023 | 352 | 0.640 |
Why?
|
| Obesity, Abdominal | 4 | 2021 | 369 | 0.630 |
Why?
|
| Longitudinal Studies | 50 | 2024 | 14751 | 0.610 |
Why?
|
| Anti-Bacterial Agents | 19 | 2021 | 7478 | 0.600 |
Why?
|
| Adult | 185 | 2025 | 223044 | 0.600 |
Why?
|
| Blood Glucose | 16 | 2024 | 6424 | 0.590 |
Why?
|
| Residence Characteristics | 15 | 2024 | 2116 | 0.590 |
Why?
|
| Carrier State | 11 | 2013 | 529 | 0.570 |
Why?
|
| Linear Models | 37 | 2025 | 5876 | 0.560 |
Why?
|
| Food Hypersensitivity | 6 | 2022 | 737 | 0.560 |
Why?
|
| Pregnancy Outcome | 14 | 2022 | 2966 | 0.560 |
Why?
|
| Health Status Disparities | 6 | 2016 | 1880 | 0.550 |
Why?
|
| Anti-Mullerian Hormone | 3 | 2025 | 420 | 0.550 |
Why?
|
| Sleep | 18 | 2024 | 4813 | 0.540 |
Why?
|
| Seafood | 5 | 2018 | 395 | 0.520 |
Why?
|
| Air Pollutants | 12 | 2025 | 2923 | 0.520 |
Why?
|
| Hormones | 2 | 2017 | 863 | 0.520 |
Why?
|
| Hair | 5 | 2024 | 508 | 0.510 |
Why?
|
| Pregnancy Trimesters | 7 | 2020 | 198 | 0.510 |
Why?
|
| Absorptiometry, Photon | 11 | 2024 | 1707 | 0.500 |
Why?
|
| Body Composition | 11 | 2023 | 2439 | 0.490 |
Why?
|
| Parturition | 5 | 2023 | 454 | 0.480 |
Why?
|
| Arsenic | 3 | 2024 | 356 | 0.480 |
Why?
|
| Parenting | 5 | 2020 | 709 | 0.470 |
Why?
|
| Environment Design | 4 | 2021 | 174 | 0.470 |
Why?
|
| Insulin Resistance | 9 | 2024 | 3985 | 0.470 |
Why?
|
| Child Behavior Disorders | 1 | 2019 | 814 | 0.470 |
Why?
|
| Pre-Eclampsia | 7 | 2024 | 1261 | 0.460 |
Why?
|
| Beverages | 7 | 2018 | 819 | 0.460 |
Why?
|
| Socioeconomic Factors | 29 | 2023 | 7838 | 0.460 |
Why?
|
| Pneumococcal Vaccines | 8 | 2013 | 414 | 0.460 |
Why?
|
| Gestational Age | 21 | 2023 | 3609 | 0.450 |
Why?
|
| Child Nutritional Physiological Phenomena | 8 | 2016 | 292 | 0.450 |
Why?
|
| Insulin-Like Growth Factor II | 4 | 2021 | 271 | 0.450 |
Why?
|
| Risk Factors | 80 | 2024 | 74840 | 0.440 |
Why?
|
| Corticotropin-Releasing Hormone | 3 | 2018 | 361 | 0.440 |
Why?
|
| Selenium | 3 | 2022 | 419 | 0.440 |
Why?
|
| Health Behavior | 11 | 2022 | 2650 | 0.440 |
Why?
|
| Fast Foods | 5 | 2019 | 220 | 0.430 |
Why?
|
| Adipokines | 4 | 2024 | 308 | 0.420 |
Why?
|
| Pneumococcal Infections | 8 | 2013 | 527 | 0.420 |
Why?
|
| Micronutrients | 4 | 2023 | 390 | 0.410 |
Why?
|
| Lead | 6 | 2023 | 879 | 0.410 |
Why?
|
| Menopause | 5 | 2024 | 1659 | 0.410 |
Why?
|
| Parents | 14 | 2020 | 3592 | 0.410 |
Why?
|
| Pregnant Women | 4 | 2020 | 575 | 0.400 |
Why?
|
| Growth Charts | 2 | 2017 | 60 | 0.400 |
Why?
|
| Vitamin D | 9 | 2024 | 3272 | 0.400 |
Why?
|
| Maternal Behavior | 5 | 2019 | 306 | 0.390 |
Why?
|
| CpG Islands | 10 | 2022 | 1207 | 0.390 |
Why?
|
| Lutein | 3 | 2022 | 123 | 0.390 |
Why?
|
| Nitric Oxide | 5 | 2025 | 2143 | 0.380 |
Why?
|
| Hydrocortisone | 5 | 2024 | 1827 | 0.380 |
Why?
|
| Growth | 4 | 2017 | 365 | 0.380 |
Why?
|
| Metabolomics | 5 | 2024 | 1668 | 0.370 |
Why?
|
| Hypersensitivity, Immediate | 3 | 2019 | 346 | 0.370 |
Why?
|
| Cross-Sectional Studies | 44 | 2024 | 26318 | 0.370 |
Why?
|
| Maternal-Fetal Exchange | 7 | 2020 | 453 | 0.370 |
Why?
|
| Thyroxine | 3 | 2020 | 672 | 0.370 |
Why?
|
| Primary Health Care | 6 | 2016 | 4736 | 0.360 |
Why?
|
| Milk | 5 | 2022 | 436 | 0.360 |
Why?
|
| Alanine Transaminase | 3 | 2018 | 607 | 0.360 |
Why?
|
| Fatty Acids, Omega-3 | 7 | 2019 | 1396 | 0.360 |
Why?
|
| Decanoic Acids | 3 | 2021 | 68 | 0.350 |
Why?
|
| Intelligence | 5 | 2024 | 923 | 0.350 |
Why?
|
| Depression, Postpartum | 3 | 2023 | 360 | 0.350 |
Why?
|
| Lipids | 9 | 2024 | 3315 | 0.350 |
Why?
|
| Republic of Belarus | 5 | 2021 | 38 | 0.340 |
Why?
|
| Bone Density | 5 | 2024 | 3491 | 0.340 |
Why?
|
| Multivariate Analysis | 34 | 2021 | 12056 | 0.340 |
Why?
|
| Polycystic Ovary Syndrome | 2 | 2025 | 389 | 0.340 |
Why?
|
| Thinness | 4 | 2020 | 482 | 0.320 |
Why?
|
| Metabolic Diseases | 3 | 2021 | 687 | 0.320 |
Why?
|
| Boston | 22 | 2025 | 9338 | 0.320 |
Why?
|
| Restaurants | 3 | 2019 | 235 | 0.320 |
Why?
|
| Age Factors | 21 | 2024 | 18380 | 0.310 |
Why?
|
| Smoking | 12 | 2020 | 9081 | 0.310 |
Why?
|
| Dietary Sucrose | 4 | 2018 | 241 | 0.300 |
Why?
|
| Parity | 9 | 2025 | 931 | 0.300 |
Why?
|
| Pregnancy Trimester, Third | 7 | 2024 | 587 | 0.300 |
Why?
|
| Streptococcus pneumoniae | 7 | 2012 | 762 | 0.290 |
Why?
|
| Skinfold Thickness | 7 | 2017 | 164 | 0.290 |
Why?
|
| Immunoglobulin E | 7 | 2022 | 1481 | 0.290 |
Why?
|
| Dermatitis, Atopic | 4 | 2018 | 729 | 0.290 |
Why?
|
| Sexual Maturation | 2 | 2019 | 246 | 0.290 |
Why?
|
| Menarche | 2 | 2021 | 532 | 0.290 |
Why?
|
| United States | 50 | 2024 | 72903 | 0.290 |
Why?
|
| Cardiovascular Diseases | 13 | 2024 | 15652 | 0.290 |
Why?
|
| Methylmercury Compounds | 2 | 2021 | 103 | 0.280 |
Why?
|
| Family | 6 | 2018 | 3209 | 0.280 |
Why?
|
| Inflammation | 12 | 2023 | 10850 | 0.270 |
Why?
|
| Respiratory Tract Infections | 6 | 2018 | 1008 | 0.270 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 3 | 2017 | 416 | 0.270 |
Why?
|
| Nasal Mucosa | 2 | 2021 | 416 | 0.270 |
Why?
|
| Bayes Theorem | 11 | 2023 | 2354 | 0.270 |
Why?
|
| Genome-Wide Association Study | 11 | 2024 | 12807 | 0.270 |
Why?
|
| Logistic Models | 32 | 2021 | 13266 | 0.260 |
Why?
|
| Insulin-Like Growth Factor I | 5 | 2017 | 1936 | 0.260 |
Why?
|
| Odds Ratio | 22 | 2022 | 9649 | 0.260 |
Why?
|
| Metabolism | 2 | 2018 | 193 | 0.260 |
Why?
|
| Analgesics, Non-Narcotic | 3 | 2020 | 366 | 0.260 |
Why?
|
| Dietary Fats | 6 | 2021 | 2002 | 0.250 |
Why?
|
| Health Promotion | 7 | 2018 | 2208 | 0.250 |
Why?
|
| Vitamin D Deficiency | 4 | 2024 | 1348 | 0.250 |
Why?
|
| Delivery, Obstetric | 3 | 2021 | 946 | 0.250 |
Why?
|
| Depression | 10 | 2023 | 8237 | 0.250 |
Why?
|
| World Health Organization | 1 | 2011 | 1328 | 0.250 |
Why?
|
| Adolescent Development | 2 | 2019 | 275 | 0.250 |
Why?
|
| Glucose Tolerance Test | 10 | 2020 | 1180 | 0.240 |
Why?
|
| Leisure Activities | 4 | 2015 | 310 | 0.240 |
Why?
|
| Particulate Matter | 7 | 2021 | 2624 | 0.240 |
Why?
|
| Hypersensitivity | 4 | 2019 | 1168 | 0.240 |
Why?
|
| Staphylococcal Infections | 5 | 2016 | 1393 | 0.240 |
Why?
|
| Follow-Up Studies | 34 | 2019 | 39193 | 0.240 |
Why?
|
| Thyrotropin | 2 | 2019 | 841 | 0.240 |
Why?
|
| Energy Intake | 7 | 2018 | 2141 | 0.240 |
Why?
|
| Hyperglycemia | 4 | 2022 | 1393 | 0.240 |
Why?
|
| Maternal Age | 9 | 2019 | 804 | 0.240 |
Why?
|
| Life Style | 8 | 2024 | 3926 | 0.230 |
Why?
|
| Vitamins | 5 | 2024 | 1630 | 0.230 |
Why?
|
| Eggs | 2 | 2022 | 182 | 0.230 |
Why?
|
| Lead Poisoning | 2 | 2019 | 318 | 0.230 |
Why?
|
| Folic Acid | 7 | 2023 | 1338 | 0.230 |
Why?
|
| Mass Screening | 4 | 2014 | 5446 | 0.230 |
Why?
|
| Young Adult | 38 | 2024 | 59889 | 0.230 |
Why?
|
| Hypertension | 10 | 2024 | 8626 | 0.220 |
Why?
|
| Metals, Heavy | 2 | 2024 | 151 | 0.220 |
Why?
|
| Food Labeling | 2 | 2019 | 181 | 0.220 |
Why?
|
| Nitrogen Dioxide | 2 | 2025 | 538 | 0.220 |
Why?
|
| Trace Elements | 2 | 2022 | 193 | 0.220 |
Why?
|
| Adolescent Behavior | 5 | 2016 | 1185 | 0.220 |
Why?
|
| Pollen | 1 | 2024 | 79 | 0.220 |
Why?
|
| Risk Assessment | 19 | 2024 | 24282 | 0.220 |
Why?
|
| Dietary Proteins | 4 | 2017 | 959 | 0.220 |
Why?
|
| Diet, Mediterranean | 3 | 2022 | 746 | 0.220 |
Why?
|
| Antihypertensive Agents | 2 | 2024 | 2033 | 0.220 |
Why?
|
| Lactation | 4 | 2023 | 391 | 0.220 |
Why?
|
| Guideline Adherence | 3 | 2024 | 2243 | 0.210 |
Why?
|
| Sweetening Agents | 3 | 2021 | 291 | 0.210 |
Why?
|
| Epigenomics | 5 | 2021 | 959 | 0.210 |
Why?
|
| Humidity | 1 | 2024 | 206 | 0.210 |
Why?
|
| Infant, Premature | 4 | 2020 | 2122 | 0.210 |
Why?
|
| Birth Order | 1 | 2023 | 93 | 0.210 |
Why?
|
| Fetal Growth Retardation | 3 | 2016 | 591 | 0.210 |
Why?
|
| Ozone | 2 | 2025 | 499 | 0.200 |
Why?
|
| Exercise | 12 | 2024 | 5937 | 0.200 |
Why?
|
| Dietary Supplements | 9 | 2021 | 3425 | 0.200 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 4 | 2016 | 705 | 0.200 |
Why?
|
| Egg Hypersensitivity | 1 | 2022 | 47 | 0.200 |
Why?
|
| Pandemics | 1 | 2022 | 8703 | 0.200 |
Why?
|
| Environment | 2 | 2021 | 1114 | 0.200 |
Why?
|
| Food Preferences | 4 | 2020 | 397 | 0.200 |
Why?
|
| Seasons | 4 | 2024 | 1524 | 0.200 |
Why?
|
| Anxiety | 6 | 2023 | 4671 | 0.190 |
Why?
|
| gamma-Tocopherol | 2 | 2020 | 29 | 0.190 |
Why?
|
| Nutrition Assessment | 2 | 2024 | 738 | 0.190 |
Why?
|
| Vehicle Emissions | 5 | 2022 | 651 | 0.190 |
Why?
|
| Nutrition Surveys | 5 | 2021 | 1741 | 0.180 |
Why?
|
| Milk Hypersensitivity | 1 | 2022 | 83 | 0.180 |
Why?
|
| Menopause, Premature | 1 | 2022 | 124 | 0.180 |
Why?
|
| Prevalence | 19 | 2025 | 15842 | 0.180 |
Why?
|
| Manganese | 2 | 2021 | 395 | 0.180 |
Why?
|
| Eating | 4 | 2021 | 1540 | 0.180 |
Why?
|
| Choline | 4 | 2022 | 510 | 0.180 |
Why?
|
| Allergens | 5 | 2024 | 1436 | 0.180 |
Why?
|
| Health Status | 4 | 2022 | 4080 | 0.170 |
Why?
|
| Weight Loss | 5 | 2020 | 2710 | 0.170 |
Why?
|
| Electronic Health Records | 8 | 2024 | 4873 | 0.170 |
Why?
|
| Nickel | 1 | 2020 | 126 | 0.170 |
Why?
|
| Food Contamination | 1 | 2021 | 194 | 0.170 |
Why?
|
| Puberty | 2 | 2021 | 491 | 0.170 |
Why?
|
| Subcutaneous Fat, Abdominal | 1 | 2020 | 91 | 0.170 |
Why?
|
| Antidepressive Agents | 2 | 2024 | 2897 | 0.170 |
Why?
|
| alpha-Tocopherol | 1 | 2020 | 127 | 0.160 |
Why?
|
| Birth Certificates | 2 | 2016 | 71 | 0.160 |
Why?
|
| Social Environment | 2 | 2015 | 1011 | 0.160 |
Why?
|
| Temperature | 2 | 2024 | 2226 | 0.160 |
Why?
|
| Genomic Imprinting | 1 | 2021 | 326 | 0.160 |
Why?
|
| Abdominal Fat | 1 | 2021 | 217 | 0.160 |
Why?
|
| Cross Infection | 3 | 2016 | 1427 | 0.160 |
Why?
|
| Hand Strength | 1 | 2022 | 462 | 0.160 |
Why?
|
| Social Support | 3 | 2019 | 2192 | 0.160 |
Why?
|
| Fructosamine | 1 | 2018 | 14 | 0.160 |
Why?
|
| Environmental Illness | 1 | 2019 | 33 | 0.160 |
Why?
|
| Thyroid Function Tests | 1 | 2020 | 293 | 0.160 |
Why?
|
| Soot | 2 | 2018 | 219 | 0.160 |
Why?
|
| Paternal Exposure | 1 | 2019 | 101 | 0.160 |
Why?
|
| Sex Factors | 11 | 2022 | 10603 | 0.160 |
Why?
|
| Drug Prescriptions | 4 | 2024 | 1662 | 0.160 |
Why?
|
| Educational Status | 7 | 2022 | 2513 | 0.160 |
Why?
|
| Education, Nonprofessional | 2 | 2015 | 32 | 0.160 |
Why?
|
| Crown-Rump Length | 1 | 2018 | 31 | 0.150 |
Why?
|
| Social Class | 4 | 2019 | 2007 | 0.150 |
Why?
|
| Satiation | 1 | 2019 | 84 | 0.150 |
Why?
|
| Fatty Acids, Omega-6 | 2 | 2011 | 226 | 0.150 |
Why?
|
| Proteobacteria | 1 | 2018 | 47 | 0.150 |
Why?
|
| Appetite Regulation | 1 | 2019 | 84 | 0.150 |
Why?
|
| Regression Analysis | 11 | 2020 | 6322 | 0.150 |
Why?
|
| Diet Surveys | 4 | 2024 | 1159 | 0.150 |
Why?
|
| Diagnostic Errors | 1 | 2005 | 1275 | 0.150 |
Why?
|
| Heart | 2 | 2024 | 4414 | 0.150 |
Why?
|
| Enterococcus | 2 | 2011 | 157 | 0.150 |
Why?
|
| Actigraphy | 2 | 2019 | 532 | 0.150 |
Why?
|
| Food Supply | 2 | 2015 | 544 | 0.150 |
Why?
|
| Behavior | 1 | 2021 | 535 | 0.150 |
Why?
|
| Prescriptions | 1 | 2020 | 388 | 0.150 |
Why?
|
| Health Maintenance Organizations | 3 | 2006 | 656 | 0.150 |
Why?
|
| Phthalic Acids | 1 | 2023 | 484 | 0.150 |
Why?
|
| Fathers | 2 | 2021 | 376 | 0.140 |
Why?
|
| Drug Utilization | 5 | 2012 | 1187 | 0.140 |
Why?
|
| Time Factors | 26 | 2020 | 40065 | 0.140 |
Why?
|
| Metabolome | 3 | 2024 | 1005 | 0.140 |
Why?
|
| Pesticide Residues | 1 | 2018 | 95 | 0.140 |
Why?
|
| Cluster Analysis | 9 | 2018 | 2721 | 0.140 |
Why?
|
| Bulimia | 2 | 2010 | 404 | 0.140 |
Why?
|
| Europe | 6 | 2020 | 3423 | 0.140 |
Why?
|
| Hypotension | 1 | 2023 | 885 | 0.140 |
Why?
|
| Computer Security | 1 | 2019 | 261 | 0.140 |
Why?
|
| Fruit | 3 | 2018 | 1166 | 0.140 |
Why?
|
| Vegetables | 3 | 2018 | 1199 | 0.140 |
Why?
|
| Privacy | 1 | 2019 | 233 | 0.140 |
Why?
|
| Sarcopenia | 1 | 2022 | 378 | 0.140 |
Why?
|
| Glucocorticoids | 2 | 2023 | 2132 | 0.140 |
Why?
|
| DNA-Binding Proteins | 3 | 2019 | 9601 | 0.140 |
Why?
|
| Vitamin E | 2 | 2018 | 869 | 0.140 |
Why?
|
| Forced Expiratory Volume | 5 | 2025 | 1828 | 0.130 |
Why?
|
| Paternity | 1 | 2016 | 14 | 0.130 |
Why?
|
| Ultrasonography, Prenatal | 3 | 2022 | 1774 | 0.130 |
Why?
|
| Breath Tests | 3 | 2024 | 297 | 0.130 |
Why?
|
| C-Reactive Protein | 8 | 2018 | 3850 | 0.130 |
Why?
|
| Nasopharynx | 6 | 2012 | 419 | 0.130 |
Why?
|
| Religion | 1 | 2019 | 376 | 0.130 |
Why?
|
| Lymphocytes | 1 | 2024 | 2599 | 0.130 |
Why?
|
| Insulin | 4 | 2021 | 6599 | 0.130 |
Why?
|
| Glycemic Index | 1 | 2018 | 400 | 0.130 |
Why?
|
| Vision, Low | 1 | 2018 | 162 | 0.130 |
Why?
|
| Weather | 1 | 2017 | 234 | 0.130 |
Why?
|
| Vaccines, Conjugate | 4 | 2013 | 334 | 0.130 |
Why?
|
| Psychomotor Disorders | 1 | 2017 | 149 | 0.130 |
Why?
|
| Siblings | 2 | 2019 | 828 | 0.130 |
Why?
|
| Patient Compliance | 2 | 2017 | 2692 | 0.130 |
Why?
|
| Thyroid Diseases | 1 | 2019 | 388 | 0.130 |
Why?
|
| Body Fat Distribution | 2 | 2014 | 246 | 0.130 |
Why?
|
| Fishes | 2 | 2016 | 606 | 0.130 |
Why?
|
| Choice Behavior | 2 | 2019 | 844 | 0.130 |
Why?
|
| Erythrocytes | 3 | 2021 | 2395 | 0.130 |
Why?
|
| Glomerular Filtration Rate | 1 | 2024 | 2233 | 0.130 |
Why?
|
| Parent-Child Relations | 3 | 2016 | 774 | 0.120 |
Why?
|
| Food | 3 | 2017 | 764 | 0.120 |
Why?
|
| North America | 4 | 2020 | 1285 | 0.120 |
Why?
|
| Snoring | 1 | 2017 | 211 | 0.120 |
Why?
|
| Peptide Hormones | 1 | 2016 | 133 | 0.120 |
Why?
|
| Surgery, Plastic | 1 | 2022 | 651 | 0.120 |
Why?
|
| Confidentiality | 1 | 2019 | 607 | 0.120 |
Why?
|
| Intra-Abdominal Fat | 1 | 2020 | 623 | 0.120 |
Why?
|
| Sports | 1 | 2001 | 698 | 0.120 |
Why?
|
| Infant Formula | 3 | 2022 | 192 | 0.120 |
Why?
|
| Eosinophilic Esophagitis | 1 | 2018 | 206 | 0.120 |
Why?
|
| Stochastic Processes | 1 | 2016 | 358 | 0.120 |
Why?
|
| Child Abuse | 1 | 2023 | 1090 | 0.120 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2018 | 565 | 0.120 |
Why?
|
| Medical Record Linkage | 1 | 2016 | 283 | 0.110 |
Why?
|
| Directive Counseling | 1 | 2016 | 171 | 0.110 |
Why?
|
| Lung | 4 | 2025 | 10033 | 0.110 |
Why?
|
| Maternal Welfare | 1 | 2014 | 113 | 0.110 |
Why?
|
| Meningococcal Vaccines | 2 | 2005 | 96 | 0.110 |
Why?
|
| Health Knowledge, Attitudes, Practice | 5 | 2013 | 4058 | 0.110 |
Why?
|
| Testosterone | 1 | 2025 | 2494 | 0.110 |
Why?
|
| Triticum | 1 | 2014 | 92 | 0.110 |
Why?
|
| Vital Capacity | 3 | 2025 | 995 | 0.110 |
Why?
|
| Calcium, Dietary | 2 | 2008 | 526 | 0.110 |
Why?
|
| Body Image | 3 | 2010 | 644 | 0.110 |
Why?
|
| Psychomotor Performance | 3 | 2011 | 1881 | 0.110 |
Why?
|
| Body Weights and Measures | 1 | 2014 | 208 | 0.110 |
Why?
|
| Drinking | 1 | 2014 | 196 | 0.110 |
Why?
|
| Infant Food | 2 | 2011 | 139 | 0.110 |
Why?
|
| Nedocromil | 1 | 2013 | 45 | 0.110 |
Why?
|
| Diabetes Mellitus | 3 | 2014 | 5891 | 0.110 |
Why?
|
| Practice Guidelines as Topic | 3 | 2024 | 7425 | 0.110 |
Why?
|
| Vancomycin Resistance | 2 | 2011 | 125 | 0.110 |
Why?
|
| Spouses | 1 | 2016 | 288 | 0.110 |
Why?
|
| Obsessive Behavior | 1 | 2013 | 48 | 0.110 |
Why?
|
| Perinatal Care | 1 | 2016 | 246 | 0.110 |
Why?
|
| Statistics as Topic | 3 | 2015 | 2352 | 0.100 |
Why?
|
| Methicillin Resistance | 2 | 2011 | 198 | 0.100 |
Why?
|
| Cytokines | 2 | 2024 | 7421 | 0.100 |
Why?
|
| Walking | 3 | 2015 | 1198 | 0.100 |
Why?
|
| Colitis, Ulcerative | 3 | 2011 | 1915 | 0.100 |
Why?
|
| Attitude to Health | 3 | 2014 | 2020 | 0.100 |
Why?
|
| Nutritional Status | 5 | 2018 | 1620 | 0.100 |
Why?
|
| Crohn Disease | 3 | 2011 | 2283 | 0.100 |
Why?
|
| Budesonide | 1 | 2013 | 163 | 0.100 |
Why?
|
| Health Education | 3 | 2008 | 1060 | 0.100 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2018 | 827 | 0.100 |
Why?
|
| Urbanization | 1 | 2012 | 101 | 0.090 |
Why?
|
| Docosahexaenoic Acids | 1 | 2018 | 916 | 0.090 |
Why?
|
| Fatty Acids | 3 | 2016 | 1806 | 0.090 |
Why?
|
| Child Day Care Centers | 2 | 2009 | 122 | 0.090 |
Why?
|
| Motor Activity | 2 | 2015 | 2704 | 0.090 |
Why?
|
| Staphylococcus aureus | 2 | 2011 | 1424 | 0.090 |
Why?
|
| Self Report | 4 | 2024 | 3770 | 0.090 |
Why?
|
| Information Dissemination | 1 | 2019 | 1142 | 0.090 |
Why?
|
| Feeding Methods | 1 | 2011 | 35 | 0.090 |
Why?
|
| Diagnostic Tests, Routine | 2 | 2006 | 790 | 0.090 |
Why?
|
| Risk | 5 | 2018 | 9591 | 0.090 |
Why?
|
| Pneumonia, Pneumococcal | 1 | 2012 | 133 | 0.090 |
Why?
|
| Models, Genetic | 1 | 2021 | 3449 | 0.090 |
Why?
|
| Autoantibodies | 1 | 2019 | 2113 | 0.090 |
Why?
|
| Weaning | 1 | 2011 | 103 | 0.090 |
Why?
|
| Achievement | 1 | 2012 | 287 | 0.090 |
Why?
|
| Developmental Disabilities | 1 | 2019 | 1519 | 0.090 |
Why?
|
| Exhalation | 2 | 2023 | 184 | 0.090 |
Why?
|
| Androgens | 1 | 2018 | 1279 | 0.090 |
Why?
|
| Probability | 4 | 2021 | 2475 | 0.090 |
Why?
|
| Population Surveillance | 1 | 2021 | 2590 | 0.090 |
Why?
|
| Information Seeking Behavior | 1 | 2011 | 116 | 0.090 |
Why?
|
| Incidence | 12 | 2019 | 21480 | 0.090 |
Why?
|
| Trans Fatty Acids | 1 | 2011 | 155 | 0.090 |
Why?
|
| Genetic Association Studies | 1 | 2019 | 2741 | 0.080 |
Why?
|
| Long Interspersed Nucleotide Elements | 1 | 2012 | 332 | 0.080 |
Why?
|
| Interleukin-6 | 4 | 2014 | 3222 | 0.080 |
Why?
|
| Glucose | 4 | 2022 | 4335 | 0.080 |
Why?
|
| Fimbriae Proteins | 1 | 2010 | 133 | 0.080 |
Why?
|
| Chronic Disease | 2 | 2022 | 9347 | 0.080 |
Why?
|
| Mother-Child Relations | 2 | 2010 | 499 | 0.080 |
Why?
|
| Reproducibility of Results | 6 | 2024 | 20124 | 0.080 |
Why?
|
| Aging | 3 | 2024 | 8731 | 0.080 |
Why?
|
| Bronchodilator Agents | 1 | 2013 | 514 | 0.080 |
Why?
|
| Communicable Disease Control | 1 | 2016 | 856 | 0.080 |
Why?
|
| Infant, Small for Gestational Age | 1 | 2012 | 469 | 0.080 |
Why?
|
| Body Size | 3 | 2022 | 459 | 0.080 |
Why?
|
| Immunoglobulin G | 2 | 2018 | 4528 | 0.080 |
Why?
|
| Patient Isolation | 1 | 2010 | 101 | 0.080 |
Why?
|
| Motor Skills | 1 | 2012 | 516 | 0.080 |
Why?
|
| Drug Resistance, Bacterial | 3 | 2012 | 1069 | 0.080 |
Why?
|
| Sentinel Surveillance | 2 | 2011 | 293 | 0.080 |
Why?
|
| Menstrual Cycle | 2 | 2022 | 540 | 0.080 |
Why?
|
| Middle Aged | 21 | 2024 | 223009 | 0.080 |
Why?
|
| Cell Proliferation | 1 | 2024 | 10429 | 0.080 |
Why?
|
| Sulfonic Acids | 2 | 2021 | 103 | 0.080 |
Why?
|
| Child Care | 1 | 2009 | 126 | 0.080 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2022 | 2310 | 0.080 |
Why?
|
| Visual Acuity | 1 | 2018 | 2708 | 0.070 |
Why?
|
| Oxidative Stress | 1 | 2019 | 3141 | 0.070 |
Why?
|
| Betaine | 3 | 2013 | 90 | 0.070 |
Why?
|
| Bulimia Nervosa | 1 | 2010 | 208 | 0.070 |
Why?
|
| Otitis Media | 2 | 2012 | 287 | 0.070 |
Why?
|
| Intelligence Tests | 2 | 2019 | 504 | 0.070 |
Why?
|
| Antioxidants | 2 | 2006 | 1670 | 0.070 |
Why?
|
| Language Development | 1 | 2009 | 183 | 0.070 |
Why?
|
| Hemodynamics | 1 | 2018 | 4184 | 0.070 |
Why?
|
| Confidence Intervals | 5 | 2017 | 2910 | 0.070 |
Why?
|
| Promoter Regions, Genetic | 1 | 2018 | 5786 | 0.070 |
Why?
|
| Computer Simulation | 1 | 2021 | 6255 | 0.070 |
Why?
|
| Health Care Costs | 2 | 2012 | 3242 | 0.070 |
Why?
|
| Hypercholesterolemia | 1 | 2014 | 1149 | 0.070 |
Why?
|
| Iron, Dietary | 1 | 2008 | 148 | 0.070 |
Why?
|
| Disease Transmission, Infectious | 2 | 2010 | 560 | 0.070 |
Why?
|
| Pregnancy in Adolescence | 1 | 2008 | 164 | 0.070 |
Why?
|
| Acid-Base Equilibrium | 1 | 2007 | 180 | 0.070 |
Why?
|
| Health Services | 1 | 2012 | 756 | 0.070 |
Why?
|
| Methicillin | 1 | 2006 | 61 | 0.070 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2019 | 2187 | 0.070 |
Why?
|
| Cattle | 2 | 2022 | 3801 | 0.070 |
Why?
|
| Pediatrics | 5 | 2015 | 3606 | 0.070 |
Why?
|
| Infant, Low Birth Weight | 3 | 2016 | 871 | 0.070 |
Why?
|
| Patient Education as Topic | 3 | 2008 | 2334 | 0.070 |
Why?
|
| Carbon | 2 | 2024 | 677 | 0.070 |
Why?
|
| Salaries and Fringe Benefits | 1 | 2009 | 258 | 0.070 |
Why?
|
| Income | 1 | 2015 | 1874 | 0.070 |
Why?
|
| Diet, Reducing | 1 | 2010 | 487 | 0.070 |
Why?
|
| Mexico | 2 | 2022 | 777 | 0.060 |
Why?
|
| Neuropsychological Tests | 4 | 2023 | 7123 | 0.060 |
Why?
|
| Motivation | 2 | 2013 | 2018 | 0.060 |
Why?
|
| Epidemiologic Methods | 1 | 2010 | 1326 | 0.060 |
Why?
|
| Systole | 4 | 2014 | 935 | 0.060 |
Why?
|
| Telomere | 2 | 2022 | 943 | 0.060 |
Why?
|
| Stress, Psychological | 3 | 2023 | 4533 | 0.060 |
Why?
|
| Dietary Carbohydrates | 3 | 2016 | 894 | 0.060 |
Why?
|
| Preconception Care | 1 | 2006 | 142 | 0.060 |
Why?
|
| Electric Impedance | 2 | 2024 | 794 | 0.060 |
Why?
|
| Sex Distribution | 3 | 2018 | 2263 | 0.060 |
Why?
|
| Australia | 2 | 2019 | 1258 | 0.060 |
Why?
|
| Vitamin B 12 | 3 | 2013 | 532 | 0.060 |
Why?
|
| Models, Theoretical | 2 | 2014 | 3564 | 0.060 |
Why?
|
| Prenatal Care | 3 | 2017 | 1160 | 0.060 |
Why?
|
| Alcohol Drinking | 1 | 2017 | 4040 | 0.060 |
Why?
|
| Drug Resistance, Microbial | 1 | 2008 | 833 | 0.060 |
Why?
|
| Databases, Factual | 5 | 2019 | 8067 | 0.060 |
Why?
|
| Hyperandrogenism | 1 | 2025 | 46 | 0.060 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2014 | 2268 | 0.060 |
Why?
|
| Netherlands | 2 | 2021 | 2277 | 0.060 |
Why?
|
| Serotyping | 3 | 2012 | 330 | 0.060 |
Why?
|
| Health Resources | 1 | 2011 | 949 | 0.060 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2016 | 4520 | 0.060 |
Why?
|
| Gram-Positive Bacterial Infections | 1 | 2006 | 339 | 0.060 |
Why?
|
| Intensive Care Units | 4 | 2016 | 3800 | 0.060 |
Why?
|
| Mitogens | 1 | 2024 | 228 | 0.060 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2019 | 3247 | 0.060 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2017 | 1896 | 0.060 |
Why?
|
| Family Characteristics | 2 | 2023 | 1001 | 0.060 |
Why?
|
| Eczema | 1 | 2006 | 246 | 0.060 |
Why?
|
| Alkanesulfonates | 1 | 2023 | 15 | 0.060 |
Why?
|
| Environmental Monitoring | 3 | 2015 | 1470 | 0.060 |
Why?
|
| Otitis | 1 | 2003 | 21 | 0.050 |
Why?
|
| New England | 2 | 2019 | 1059 | 0.050 |
Why?
|
| Vancomycin | 1 | 2006 | 504 | 0.050 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 2 | 2009 | 592 | 0.050 |
Why?
|
| Rhinitis, Allergic, Seasonal | 1 | 2024 | 101 | 0.050 |
Why?
|
| Respiratory Function Tests | 2 | 2020 | 1693 | 0.050 |
Why?
|
| Case Management | 1 | 2005 | 277 | 0.050 |
Why?
|
| Particle Size | 2 | 2019 | 1631 | 0.050 |
Why?
|
| Gene Expression Regulation | 1 | 2021 | 11888 | 0.050 |
Why?
|
| Cardiovascular System | 1 | 2010 | 841 | 0.050 |
Why?
|
| Spirometry | 2 | 2018 | 929 | 0.050 |
Why?
|
| Clinical Clerkship | 1 | 2009 | 568 | 0.050 |
Why?
|
| Hospitals | 1 | 2016 | 3888 | 0.050 |
Why?
|
| Age Distribution | 3 | 2013 | 2858 | 0.050 |
Why?
|
| Bupropion | 1 | 2024 | 303 | 0.050 |
Why?
|
| Trees | 1 | 2022 | 58 | 0.050 |
Why?
|
| Thyroid Gland | 2 | 2020 | 1180 | 0.050 |
Why?
|
| Schools, Medical | 1 | 2009 | 876 | 0.050 |
Why?
|
| Adipose Tissue | 3 | 2019 | 3312 | 0.050 |
Why?
|
| Psychiatric Status Rating Scales | 3 | 2019 | 6014 | 0.050 |
Why?
|
| Case-Control Studies | 5 | 2019 | 22223 | 0.050 |
Why?
|
| Vocabulary | 1 | 2022 | 165 | 0.050 |
Why?
|
| Reward | 1 | 2009 | 981 | 0.050 |
Why?
|
| Retrospective Studies | 13 | 2022 | 81514 | 0.050 |
Why?
|
| Milk Proteins | 1 | 2022 | 161 | 0.050 |
Why?
|
| Hyperphagia | 1 | 2022 | 139 | 0.050 |
Why?
|
| Carotenoids | 1 | 2004 | 619 | 0.050 |
Why?
|
| Mass Media | 1 | 2004 | 301 | 0.050 |
Why?
|
| Models, Structural | 1 | 2021 | 338 | 0.050 |
Why?
|
| Citalopram | 1 | 2024 | 402 | 0.050 |
Why?
|
| Cadmium | 1 | 2022 | 218 | 0.050 |
Why?
|
| Patient Participation | 1 | 2010 | 1455 | 0.050 |
Why?
|
| Predictive Value of Tests | 4 | 2011 | 15398 | 0.050 |
Why?
|
| Anatomy, Cross-Sectional | 1 | 2021 | 139 | 0.050 |
Why?
|
| Models, Statistical | 2 | 2014 | 5089 | 0.050 |
Why?
|
| Mediator Complex | 1 | 2021 | 106 | 0.050 |
Why?
|
| Teaching | 1 | 2009 | 1169 | 0.050 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2022 | 12240 | 0.050 |
Why?
|
| Calcium Channel Blockers | 1 | 2024 | 686 | 0.040 |
Why?
|
| Cytosine | 1 | 2022 | 213 | 0.040 |
Why?
|
| Animals | 12 | 2022 | 168764 | 0.040 |
Why?
|
| Guanine | 1 | 2022 | 282 | 0.040 |
Why?
|
| Anti-Infective Agents | 2 | 2016 | 986 | 0.040 |
Why?
|
| Phenotype | 4 | 2019 | 16721 | 0.040 |
Why?
|
| Mass Spectrometry | 2 | 2018 | 2194 | 0.040 |
Why?
|
| Faculty, Medical | 1 | 2009 | 1219 | 0.040 |
Why?
|
| Health Care Surveys | 3 | 2014 | 2424 | 0.040 |
Why?
|
| Drug Utilization Review | 1 | 2001 | 248 | 0.040 |
Why?
|
| Public Health | 2 | 2016 | 2680 | 0.040 |
Why?
|
| Amenorrhea | 1 | 2023 | 470 | 0.040 |
Why?
|
| Christianity | 1 | 2019 | 52 | 0.040 |
Why?
|
| Zinc | 1 | 2024 | 675 | 0.040 |
Why?
|
| Physical Examination | 1 | 2005 | 1266 | 0.040 |
Why?
|
| Mental Health | 1 | 2014 | 3278 | 0.040 |
Why?
|
| Transcription Factors | 1 | 2019 | 12131 | 0.040 |
Why?
|
| Internet | 1 | 2011 | 3106 | 0.040 |
Why?
|
| Reference Values | 3 | 2012 | 4908 | 0.040 |
Why?
|
| Intention | 1 | 2022 | 346 | 0.040 |
Why?
|
| Oceania | 1 | 2018 | 21 | 0.040 |
Why?
|
| Health Surveys | 4 | 2011 | 4056 | 0.040 |
Why?
|
| Superior Sagittal Sinus | 1 | 2018 | 15 | 0.040 |
Why?
|
| Urban Population | 2 | 2018 | 2040 | 0.040 |
Why?
|
| Pituitary-Adrenal System | 1 | 2022 | 547 | 0.040 |
Why?
|
| Fatty Acids, Volatile | 1 | 2019 | 100 | 0.040 |
Why?
|
| Nonprescription Drugs | 1 | 2020 | 119 | 0.040 |
Why?
|
| Sensitivity and Specificity | 3 | 2013 | 14652 | 0.040 |
Why?
|
| Quality of Health Care | 1 | 2013 | 4300 | 0.040 |
Why?
|
| ROC Curve | 2 | 2018 | 3620 | 0.040 |
Why?
|
| Phosphates | 1 | 2022 | 763 | 0.040 |
Why?
|
| Kidney | 2 | 2024 | 7066 | 0.040 |
Why?
|
| Selection Bias | 1 | 2020 | 361 | 0.040 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2022 | 697 | 0.040 |
Why?
|
| Puberty, Precocious | 1 | 2019 | 163 | 0.040 |
Why?
|
| Iodide Peroxidase | 1 | 2019 | 297 | 0.040 |
Why?
|
| Plasma | 1 | 2021 | 579 | 0.040 |
Why?
|
| Puerperal Disorders | 1 | 2020 | 306 | 0.040 |
Why?
|
| Depressive Disorder | 1 | 2010 | 3714 | 0.040 |
Why?
|
| Aged | 9 | 2024 | 171117 | 0.030 |
Why?
|
| Penicillin Resistance | 2 | 2009 | 77 | 0.030 |
Why?
|
| Prognosis | 5 | 2019 | 29922 | 0.030 |
Why?
|
| Aryldialkylphosphatase | 1 | 2017 | 64 | 0.030 |
Why?
|
| Intention to Treat Analysis | 1 | 2018 | 416 | 0.030 |
Why?
|
| Education, Medical | 1 | 2009 | 1746 | 0.030 |
Why?
|
| Blood Pressure Determination | 1 | 2020 | 647 | 0.030 |
Why?
|
| Anemia | 1 | 2006 | 1511 | 0.030 |
Why?
|
| Triglycerides | 2 | 2014 | 2441 | 0.030 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 2022 | 1133 | 0.030 |
Why?
|
| Norway | 1 | 2017 | 499 | 0.030 |
Why?
|
| Sex | 1 | 2016 | 53 | 0.030 |
Why?
|
| Disease Notification | 2 | 2006 | 95 | 0.030 |
Why?
|
| Greece | 1 | 2017 | 340 | 0.030 |
Why?
|
| South Australia | 1 | 2016 | 27 | 0.030 |
Why?
|
| DNA, Mitochondrial | 1 | 2021 | 869 | 0.030 |
Why?
|
| Suburban Population | 1 | 2016 | 54 | 0.030 |
Why?
|
| Self Care | 2 | 2015 | 800 | 0.030 |
Why?
|
| Cognition Disorders | 1 | 2010 | 3967 | 0.030 |
Why?
|
| Education, Medical, Continuing | 1 | 2001 | 830 | 0.030 |
Why?
|
| Fructose | 1 | 2018 | 286 | 0.030 |
Why?
|
| Feasibility Studies | 2 | 2019 | 5302 | 0.030 |
Why?
|
| Data Interpretation, Statistical | 1 | 2005 | 2686 | 0.030 |
Why?
|
| Pamphlets | 1 | 2015 | 71 | 0.030 |
Why?
|
| Brazil | 1 | 2020 | 1248 | 0.030 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2018 | 538 | 0.030 |
Why?
|
| Proportional Hazards Models | 2 | 2008 | 12509 | 0.030 |
Why?
|
| Antibody Specificity | 1 | 2017 | 1061 | 0.030 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 2017 | 357 | 0.030 |
Why?
|
| Prehypertension | 1 | 2015 | 63 | 0.030 |
Why?
|
| Starch | 1 | 2015 | 81 | 0.030 |
Why?
|
| Longevity | 1 | 2023 | 1087 | 0.030 |
Why?
|
| Drug Administration Schedule | 2 | 2018 | 4850 | 0.030 |
Why?
|
| New Zealand | 1 | 2016 | 359 | 0.030 |
Why?
|
| Nitrogen Oxides | 1 | 2015 | 128 | 0.030 |
Why?
|
| Marital Status | 1 | 2016 | 426 | 0.030 |
Why?
|
| Serum Albumin | 1 | 2018 | 675 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2018 | 1638 | 0.030 |
Why?
|
| Prenatal Diagnosis | 1 | 2021 | 1268 | 0.030 |
Why?
|
| Chromatography, Liquid | 1 | 2018 | 990 | 0.030 |
Why?
|
| C-Peptide | 1 | 2016 | 443 | 0.030 |
Why?
|
| Emotions | 2 | 2017 | 2763 | 0.030 |
Why?
|
| Leukocytes | 1 | 2022 | 2027 | 0.030 |
Why?
|
| Bone and Bones | 1 | 2024 | 2554 | 0.030 |
Why?
|
| Drinking Behavior | 1 | 2014 | 101 | 0.030 |
Why?
|
| Microbial Sensitivity Tests | 2 | 2012 | 1971 | 0.030 |
Why?
|
| Taste | 1 | 2015 | 190 | 0.030 |
Why?
|
| Affective Symptoms | 1 | 2017 | 417 | 0.030 |
Why?
|
| Family Practice | 2 | 2008 | 508 | 0.030 |
Why?
|
| Diet Records | 1 | 2015 | 425 | 0.030 |
Why?
|
| Pulse | 1 | 2014 | 215 | 0.030 |
Why?
|
| Causality | 1 | 2020 | 1248 | 0.030 |
Why?
|
| Faculty | 1 | 2017 | 384 | 0.030 |
Why?
|
| Adolescent Nutritional Physiological Phenomena | 2 | 2005 | 59 | 0.030 |
Why?
|
| Perception | 1 | 2019 | 1205 | 0.030 |
Why?
|
| Immunization | 1 | 2017 | 1219 | 0.030 |
Why?
|
| Therapy, Computer-Assisted | 1 | 2015 | 265 | 0.030 |
Why?
|
| Hospitals, Maternity | 1 | 2013 | 32 | 0.030 |
Why?
|
| Sodium Chloride, Dietary | 1 | 2015 | 303 | 0.030 |
Why?
|
| DNA Copy Number Variations | 1 | 2021 | 2045 | 0.030 |
Why?
|
| Delivery of Health Care | 1 | 2011 | 5370 | 0.030 |
Why?
|
| Consumer Advocacy | 1 | 2013 | 83 | 0.030 |
Why?
|
| Creatinine | 1 | 2018 | 1915 | 0.020 |
Why?
|
| Growth and Development | 1 | 2012 | 46 | 0.020 |
Why?
|
| Hospitalization | 1 | 2012 | 10808 | 0.020 |
Why?
|
| Fetal Weight | 1 | 2012 | 90 | 0.020 |
Why?
|
| Waist-Hip Ratio | 1 | 2013 | 520 | 0.020 |
Why?
|
| Cities | 1 | 2014 | 543 | 0.020 |
Why?
|
| Multilocus Sequence Typing | 1 | 2011 | 102 | 0.020 |
Why?
|
| Hunger | 1 | 2013 | 207 | 0.020 |
Why?
|
| Urban Health | 1 | 2014 | 530 | 0.020 |
Why?
|
| Carbon Monoxide | 1 | 2015 | 560 | 0.020 |
Why?
|
| Poverty | 1 | 2023 | 2714 | 0.020 |
Why?
|
| Diastole | 1 | 2014 | 785 | 0.020 |
Why?
|
| Finland | 1 | 2012 | 608 | 0.020 |
Why?
|
| Dietary Fiber | 1 | 2015 | 767 | 0.020 |
Why?
|
| Sex Characteristics | 2 | 2016 | 2643 | 0.020 |
Why?
|
| Psychological Tests | 1 | 2013 | 644 | 0.020 |
Why?
|
| Hemoglobins | 2 | 2008 | 1530 | 0.020 |
Why?
|
| Sexual Partners | 1 | 2016 | 804 | 0.020 |
Why?
|
| Bacterial Typing Techniques | 1 | 2011 | 263 | 0.020 |
Why?
|
| Medicaid | 3 | 2012 | 2833 | 0.020 |
Why?
|
| Sulfonamides | 1 | 2020 | 1984 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2019 | 3797 | 0.020 |
Why?
|
| Colonic Neoplasms | 1 | 2002 | 2531 | 0.020 |
Why?
|
| Genetic Loci | 1 | 2020 | 2631 | 0.020 |
Why?
|
| Qualitative Research | 2 | 2014 | 3139 | 0.020 |
Why?
|
| Peptide YY | 1 | 2011 | 135 | 0.020 |
Why?
|
| Information Storage and Retrieval | 1 | 2016 | 834 | 0.020 |
Why?
|
| Geographic Information Systems | 1 | 2012 | 280 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2014 | 4348 | 0.020 |
Why?
|
| Analysis of Variance | 2 | 2012 | 6203 | 0.020 |
Why?
|
| Methionine | 1 | 2012 | 569 | 0.020 |
Why?
|
| Behavior Therapy | 1 | 2015 | 884 | 0.020 |
Why?
|
| Operon | 1 | 2010 | 371 | 0.020 |
Why?
|
| Social Behavior | 1 | 2016 | 1146 | 0.020 |
Why?
|
| Ghrelin | 1 | 2011 | 255 | 0.020 |
Why?
|
| Computers | 1 | 2011 | 588 | 0.020 |
Why?
|
| Consumer Health Information | 1 | 2011 | 215 | 0.020 |
Why?
|
| Fasting | 1 | 2015 | 1606 | 0.020 |
Why?
|
| Biometry | 1 | 2012 | 571 | 0.020 |
Why?
|
| Leg | 1 | 2014 | 1080 | 0.020 |
Why?
|
| Gene Regulatory Networks | 1 | 2017 | 1748 | 0.020 |
Why?
|
| Interpersonal Relations | 1 | 2016 | 1432 | 0.020 |
Why?
|
| Mitochondria | 1 | 2021 | 3673 | 0.020 |
Why?
|
| Focus Groups | 1 | 2014 | 1459 | 0.020 |
Why?
|
| Aged, 80 and over | 3 | 2024 | 59489 | 0.020 |
Why?
|
| Cholesterol, HDL | 1 | 2014 | 1811 | 0.020 |
Why?
|
| Severity of Illness Index | 2 | 2021 | 15880 | 0.020 |
Why?
|
| Insurance Claim Reporting | 1 | 2008 | 166 | 0.020 |
Why?
|
| Sex Hormone-Binding Globulin | 1 | 2010 | 558 | 0.020 |
Why?
|
| Rural Population | 1 | 2018 | 2317 | 0.020 |
Why?
|
| Erythrocyte Indices | 1 | 2008 | 145 | 0.020 |
Why?
|
| Nasal Cavity | 1 | 2009 | 307 | 0.020 |
Why?
|
| Physicians | 1 | 2005 | 4588 | 0.020 |
Why?
|
| Observer Variation | 1 | 2013 | 2615 | 0.020 |
Why?
|
| Acids | 1 | 2007 | 125 | 0.020 |
Why?
|
| International Classification of Diseases | 1 | 2013 | 935 | 0.020 |
Why?
|
| Minority Groups | 1 | 2014 | 1207 | 0.020 |
Why?
|
| Cockroaches | 1 | 2006 | 93 | 0.020 |
Why?
|
| Antigens, Dermatophagoides | 1 | 2006 | 101 | 0.020 |
Why?
|
| Group Practice | 1 | 2007 | 149 | 0.020 |
Why?
|
| Academic Medical Centers | 2 | 2006 | 2780 | 0.020 |
Why?
|
| DNA | 1 | 2020 | 7202 | 0.020 |
Why?
|
| Nose | 1 | 2010 | 519 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2017 | 3607 | 0.020 |
Why?
|
| Circadian Rhythm | 1 | 2017 | 2592 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2018 | 10729 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 1 | 2008 | 1600 | 0.020 |
Why?
|
| Counseling | 1 | 2013 | 1551 | 0.020 |
Why?
|
| Head | 1 | 2011 | 925 | 0.020 |
Why?
|
| Cholesterol | 1 | 2014 | 2898 | 0.020 |
Why?
|
| Insect Proteins | 1 | 2006 | 253 | 0.020 |
Why?
|
| Interviews as Topic | 1 | 2013 | 2739 | 0.020 |
Why?
|
| Acute Disease | 2 | 2006 | 7232 | 0.020 |
Why?
|
| DNA, Bacterial | 1 | 2010 | 1477 | 0.020 |
Why?
|
| Decision Support Techniques | 1 | 2015 | 2003 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2021 | 9525 | 0.010 |
Why?
|
| Age of Onset | 1 | 2012 | 3344 | 0.010 |
Why?
|
| Social Marketing | 1 | 2004 | 51 | 0.010 |
Why?
|
| Interleukin-13 | 1 | 2006 | 388 | 0.010 |
Why?
|
| Family Health | 1 | 2009 | 1253 | 0.010 |
Why?
|
| Persuasive Communication | 1 | 2004 | 58 | 0.010 |
Why?
|
| Cysteine Endopeptidases | 1 | 2006 | 542 | 0.010 |
Why?
|
| Bacterial Infections | 1 | 2012 | 1387 | 0.010 |
Why?
|
| Monte Carlo Method | 1 | 2009 | 1238 | 0.010 |
Why?
|
| Sampling Studies | 1 | 2005 | 607 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2015 | 8529 | 0.010 |
Why?
|
| Memory | 1 | 2013 | 2190 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2022 | 16047 | 0.010 |
Why?
|
| Embryonic and Fetal Development | 1 | 2003 | 419 | 0.010 |
Why?
|
| Culture | 1 | 2005 | 622 | 0.010 |
Why?
|
| Interleukin-10 | 1 | 2006 | 1183 | 0.010 |
Why?
|
| Penicillins | 1 | 2004 | 404 | 0.010 |
Why?
|
| Treatment Outcome | 3 | 2016 | 65188 | 0.010 |
Why?
|
| Personal Satisfaction | 1 | 2005 | 641 | 0.010 |
Why?
|
| Washington | 1 | 2001 | 314 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2022 | 18071 | 0.010 |
Why?
|
| Insurance Coverage | 1 | 2012 | 1944 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2014 | 8733 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2014 | 12437 | 0.010 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2006 | 1857 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2002 | 13648 | 0.010 |
Why?
|
| Iron | 1 | 2008 | 1816 | 0.010 |
Why?
|
| Drug Resistance | 1 | 2005 | 1591 | 0.010 |
Why?
|
| Demography | 1 | 2004 | 1641 | 0.010 |
Why?
|
| Disease Progression | 1 | 2015 | 13632 | 0.010 |
Why?
|
| Interferon-gamma | 1 | 2006 | 3160 | 0.010 |
Why?
|
| Forecasting | 1 | 2007 | 2936 | 0.010 |
Why?
|
| Activities of Daily Living | 1 | 2006 | 2415 | 0.010 |
Why?
|
| SEER Program | 1 | 2002 | 1446 | 0.010 |
Why?
|
| Patient-Centered Care | 1 | 2006 | 1458 | 0.010 |
Why?
|
| Administration, Oral | 1 | 2004 | 4015 | 0.010 |
Why?
|
| Data Collection | 1 | 2005 | 3318 | 0.010 |
Why?
|
| Recurrence | 1 | 2008 | 8501 | 0.010 |
Why?
|
| Students, Medical | 1 | 2009 | 1959 | 0.010 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2002 | 3537 | 0.010 |
Why?
|
| Heart Rate | 1 | 2004 | 4204 | 0.010 |
Why?
|
| Decision Making | 1 | 2005 | 3965 | 0.010 |
Why?
|
| Attitude of Health Personnel | 1 | 2005 | 3925 | 0.010 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2005 | 3230 | 0.010 |
Why?
|
| Insurance, Health | 1 | 2003 | 2521 | 0.010 |
Why?
|
| Models, Biological | 1 | 2004 | 9443 | 0.000 |
Why?
|
| Medicare | 1 | 2002 | 6823 | 0.000 |
Why?
|